Hired and retired: New appointments in the biopharma industry
Catalent, SK bioscience and CureVac are among the companies welcoming new faces to top jobs.
Archives for February 6, 2023
AstraZeneca automates DNA synthesis to slash costs and timelines
AstraZeneca has cut the cost and time needed to complete DNA synthesis by integrating an assembly framework into Benchling.
Pfizer’s 2023 pipeline: ‘We potentially will have the largest number of new product and indication launches that we’ve ever had in such a short period of time’
Pfizer currently has an unprecedented number of anticipated launches, says its CEO: with the company expecting to have up to 19 new products or indications in the market in the next 18 months.
FDA to review Sandoz's BLA for biosimilar tackling osteoporosis in postmenopausal women
The Novartis subsidiary said its BLA submission to the US FDA is supported by a comprehensive analytical and clinical data package.
Bionova Scientific aims to quadruple GMP biologics manufacturing capacity
The project is the first phase of a wider strategic initiative to expand capacity and enhance end-to-end biologics development and manufacturing services at the US CDMO.